EIN 33-0319501

Torrey Pines Institute for Molecular Studies

IRS 501(c) type
501(c)(3)
Num. employees
44
State
Year formed
1988
Most recent tax filings
2019-06-01
Description
We pursue innovative research that leads to the understanding and treatment of major medical conditions, including multiple sclerosis, aids, Alzheimer's disease, pain, arthritis, heart disease, many types of cancer, and more.
Also known as...
Multiple Sclerosis National Research Institute
Total revenues
$5,106,694
2018
Total expenses
$6,551,996
2018
Total assets
$13,314,738
2018
Num. employees
44
2018

Program areas at Torrey Pines Institute for Molecular Studies

Cancer and aging:cancer is not one disease, but a group of more than 100 different diseases. Researchers and doctors are finding new ways to prevent and treat cancer, but it is still common and often deadly. The american cancer society estimates that cancer is responsible for about 10% of deaths throughout the world, and in the u.s. alone, half of all men and a third of all women will experience cancer during their lifetime. Some of the most common cancers are breast cancer, prostate cancer, and lung cancer. Torrey Pines Institute scientists are conducting intensive Research into each of these cancers.torrey Pines Institute scientists are at the forefront of the search for new ways to prevent and treat many types of cancer including breast cancer, lung cancer and prostate cancer. We have programs that are searching for new drugs that cripple essential pathways inside cancer cells. We are harnessing the power of the immune system to seek out and destroy different types of cancer. Our scientists are also leading Research to understand the basic inner workings of cancer cells, so that we may find the triggers that start uncontrolled growth. All of our researchers collaborate extensively, because a breakthrough in understanding one cancer often increases our understanding of other cancers.principal investigators are working on several challenges in the area of cancer. Scientists are discovering ways to boost our natural immunity, using vaccines that train our immune cells to kill cancer cells, or to damage the blood vessels that sustain growth of tumors, understanding how cancer cells move around the body to form metastases, and how this can be targeted with new therapies, discovering new drugs that kill cancer cells by interfering with critical pathways inside the cells and making them sensitive to therapy, understanding the relationship between obesity and cancer, and discovering how fats in the bloodstream can protect cancer cells from our immune system. Scientists are also discovering how cancer can develop from 'stem cells' that can keep dividing when most other cancer cells have been destroyed and developing strategies to deliver therapeutic genes to tumors. The Research is funded by grants received from the National institutes of health, department of defense, and alzheimer's and aging Research center, Florida department of health and generous donations from the public.alzheimer's disease is a complex and an irreversible neurodegenerative disorder of the elderly characterized by progressive cognitive decline and loss of memory. Alzheimer's disease is considered as the second most feared disease after cancer. This is because memory loss occurs to such an extent that the affected patients can't recognize their own family members and friends and they may completely depend on nursing care as the disease advances. It is estimated that nearly 5.3 million patients in the united states alone or 35.6 million patients worldwide suffer from alzheimer's disease. Because there is no effective treatment available now to at least slowdown alzheimer's disease, and also because of gradual increase in life span of human beings due to improved health care, by 2050, 115.6 million people worldwide are predicted to suffer from alzheimer's disease. The current fda approved drugs are useful only for temporary symptomatic relief, but they cannot reverse or at least slow down the disease from further deterioration since they were not designed to treat the underlying cause of the disease.alzheimer's disease is pathologically characterized by the presence of neurofibrillary tangles inside the neuron, the fundamental units of the brain. Tangles are formed as a result of alteration in a protein called tau which affects transportation of essential materials within the neuron. The disease is also characterized by the accumulation of toxic protein called amyloid beta outside the neuron. The aggregation of these toxic proteins is believed to be responsible for loss of synapses (junctions), the points where two neurons communicate with each other. There are an estimated 200 billion neurons in an adult human brain, and each neuron can make one thousand to ten thousand connections with other neurons via these synapses. Thus within human brain there are an unimaginable number of trillions of connections that far exceeds the number of stars in 1500 galaxies in the universe. With the gradual loss of these synapses, the complex network of neurons, which is indispensable for proper functioning of the brain, are lost in the alzheimer's brains leading to loss of memory, poor judgment and other debilitating conditions affecting day to day life of alzheimer's.mitochondria convert molecules derived from food to those that provide energy to the cell. In the process small amounts of free radicals are produced, however under conditions where mitochondria are excessively stressed they produce large amounts of free radicals causing severe damage and can lead to the death of the cell. As people age our cells produce more of these free radicals and recent Studies have provided evidence of induction of free radicals by amyloid beta a peptide long associated with alzheimer's disease. Nerve cells in ad patients are less efficient at generating energy and proteins involved in energy production in the mitochondria are often damaged by free radicals.the ultimate goal of tpims' alzheimer's Research is to develop cause-based therapy that will modify the disease process as a whole and not just treat symptoms. Principal investigators are focusing on several Research projects on alzheimer's disease. Scientists are conducting Research to identify and characterize those proteins which are responsible for producing amyloid beta peptide, as well as identify and characterize those molecules which mediate loss of synapses in alzheimer's disease.
Pain management:the cost of chronic pain in the u.s. Exceeds $70 billion annually, with direct costs for pain associated with diabetes alone exceeding $10 billion. Unfortunately, long term treatments with opiates for chronic pain have high dropout rates and Studies suggest that pain relief by opiates become masked by development of adverse signals between cells that are responsible for tolerance, dependence, addiction, and chronic pain.the Institute is interested in finding compounds that alleviate pain through signal prevention or by resetting the body to restore the natural capacity to alleviate pain. Pain facilitation, opiate tolerance, and addiction can be linked to inter-communication between neurons and immune cells in the brain.a compound discovered by scientists at Torrey Pines has recently completed phase ii clinical trials for the treatment of pain.principal investigators are working on several challenges in the area of pain management. Scientists are discovering compounds that alleviate pain through signal prevention or by resetting the body to restore the natural capacity to alleviate pain, refining the biological properties of synthesized cone snail venom to develop more effective pain drugs with fewer side effects than present options like opiates, and developing new therapies for mood disorders, learning and memory disorders, and drug abuse by identifying and characterizing the neurotransmitter systems that underlie the behaviors of hormones and how they are released in response to stress.
Chemistry:when Torrey Pines Institute for Molecular Studies first opened its laboratories twenty-two years ago, the main Research focus was in the area of chemistry. The Research resulted in a new method of drug discovery called, "combinatorial chemistry", which is now being used by researchers worldwide to help find new drugs and diagnostics for diseases. This group also supports all of the other Research being conducted at the Institute by providing the "chemical libraries" needed for groups in their search for vaccines, therapeutics, and diagnostic compounds. As a result of the methods invested and developed in tpims chemistry laboratories, we have been able to make significant progress in all Research groups. Tpims now partners with other Research centers to make compounds to be used by researchers all over the world in areas such as cancer Research. Research results have been presented to the public in hundreds of scientific journal articles and in scientific presentations worldwide. Tpims has trained many scientists in these methods not only in san diego and Florida, but also across the united states and around the world. This group is supported by the National institutes of health, the state of Florida, various corporate Research contracts and generous donations from the public.

Who funds Torrey Pines Institute for Molecular Studies

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Alzheimers and Aging Research CenterResearch Grant$510,370
Diabetes National Research GroupResearch$150,000
Medical Research Charities (MRC)To Assist in the Organization's Exempt Purposes.$70,205
...and 3 more grants received
Federal funding details
Federal agencyProgram nameAmount
Department of Health and Human ServicesNATIONAL INSTITUTE OF HEALTH DIRECT PROGRAM$2,308,233
Department of DefenseMILITARY MEDICAL RESEARCH AND DEVELOPMENT$512,870
Department of Health and Human ServicesDRUG ABUSE AND ADDICTION RESEARCH PROGRAMS$182,838
...and 6 more federal grants / contracts

Personnel at Torrey Pines Institute for Molecular Studies

NameTitleCompensation
Richard A. HoughtenFounder , President and Chief Executive Officer$401,297
Donald B. CooperChief Financial Officer$134,095
Pamela G. HoughtenVice President of Administration and Outreach and Corporate Secretary$79,500
Gregg B. FieldsVice President of Scientific Affairs and Full Member$252,000
X XChief Business and Financial Officer

Financials for Torrey Pines Institute for Molecular Studies

RevenuesFYE 06/2018
Total grants, contributions, etc.$3,830,176
Program services$431,050
Investment income and dividends$1,457
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$740,860
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$103,151
Total revenues$5,106,694

Form 990s for Torrey Pines Institute for Molecular Studies

Fiscal year endingDate received by IRSFormPDF link
2019-062021-04-28990View PDF
2018-062019-07-30990View PDF
2017-062018-04-02990View PDF
2016-062017-05-05990View PDF
2015-062016-04-28990View PDF
...and 6 more Form 990s
Data update history
July 22, 2022
Received grants
Identified 4 new grant, including a grant for $510,370 from Alzheimers and Aging Research Center
August 18, 2021
Posted financials
Added Form 990 for fiscal year 2019
November 28, 2020
Used new vendors
Identified 6 new vendors, including , , , , , and
November 21, 2020
Received grants
Identified 2 new grant, including a grant for $150,000 from Diabetes National Research Group
September 30, 2020
Posted financials
Added Form 990 for fiscal year 2018
Nonprofit Types
Grantmaking organizationsDisease research fundraisersResearch centersCharities
Issues
Science and technologyDiseases and disorders
Characteristics
Conducts researchLobbyingNational levelReceives government fundingTax deductible donations
General information
Address
11350 SW Village Pkwy
Port Saint Lucie, FL 34987
Metro area
Port St. Lucie, FL
County
St. Lucie County, FL
Website URL
tpims.org/ 
Phone
(772) 345-4800
Facebook page
tpims 
IRS details
EIN
33-0319501
Fiscal year end
June
Taxreturn type
Form 990
Year formed
1988
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
U50: Biological, Life Science Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
Free account sign-up

Want updates when Torrey Pines Institute for Molecular Studies has new information, or want to find more organizations like Torrey Pines Institute for Molecular Studies?

Create free Cause IQ account